Collaborative drug therapy management and comprehensive medication management - 2015

Pharmacotherapy

Volumn 35, Issue 4, 2015, Pages e39-e50

  McBane, Sarah E ^a   Dopp, Anna L ^b   Abe, Andrew ^b   Benavides, Sandra ^b   Chester, Elizabeth A ^b   Dixon, Dave L ^b   Dunn, Michaelia ^b   Johnson, Melissa D ^b   Nigro, Sarah J ^b   Rothrock Christian, Tracie ^b   Schwartz, Amy H ^b   Thrasher, Kim ^b   Walker, Scot ^b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b NONE

Author keywords

clinical pharmacist; clinical pharmacy; collaborative drug therapy management; collaborative practice; comprehensive medication management

Indexed keywords

ACCREDITATION; ARTICLE; BILLING AND CLAIMS; CLINICAL PHARMACY; CLINICAL PRACTICE; COLLABORATIVE DRUG THERAPY MANAGEMENT; COMPREHENSIVE MEDICATION MANAGEMENT; COOPERATION; COST BENEFIT ANALYSIS; DOCUMENTATION; DRUG COST; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH CARE QUALITY; HEALTH PROGRAM; HUMAN; MEDICAL DECISION MAKING; MEDICATION THERAPY MANAGEMENT; PATIENT CARE; PHARMACIST; PROFESSIONAL COMPETENCE; PUBLIC-PRIVATE PARTNERSHIP; PUBLICATION; DRUG THERAPY; HOSPITAL PHARMACY; LAW; ORGANIZATION AND MANAGEMENT; TRENDS; UNITED STATES;

DRUG THERAPY; HUMANS; LEGISLATION, PHARMACY; PATIENT CARE TEAM; PATIENT PROTECTION AND AFFORDABLE CARE ACT; PATIENT-CENTERED CARE; PHARMACY SERVICE, HOSPITAL; UNITED STATES;

EID: 84927779600     PISSN: 02770008     EISSN: 18759114     Source Type: Journal    
DOI: 10.1002/phar.1563     Document Type: Article

References (69)

1. Carmichael JM, O'Connell MB, Devine B, et al. Collaborative drug therapy management by pharmacists. Pharmacotherapy 1997; 17: 1050-61.
2. Hammond RW, Schwartz AH, Campbell MJ, et al. Collaborative drug therapy management by pharmacists-2003. Pharmacotherapy 2003; 23: 1210-25.
3. Medicare Prescription Drug, Improvement, and Modernization Act of 2003. Available from www.govtrack.us/congress/bills/108/hr1. Accessed January 6, 2015.
4. Patient Protection and Affordable Care Act. Available from www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed January 6, 2015.
5. Giberson S, Yoder S, Lee MP,. Improving patient and health system outcomes through advanced pharmacy practice. A report to the U.S. Surgeon General. Washington, DC: U.S. Public Health Service, Office of the Chief Pharmacist, December 2011. Available from www.usphs.gov/corpslinks/pharmacy/documents/2011advancedpharmacypracticereporttotheussg.pdf. Accessed January 6, 2015.
6. Benjamin R,. Support letter from the United States Surgeon General. Available from http://www.usphs.gov/corpslinks/pharmacy/documents/2011SupportLetterFromUSSG.pdf. Accessed January 19, 2015.
7. Morrison CM, Glover D, Gilchrist SM, et al. A program guide for public health: partnering with pharmacists in the prevention and control of chronic diseases. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, August 2012. Available from www.cdc.gov/dhdsp/programs/nhdsp-program/docs/pharmacist-guide.pdf. Accessed January 6, 2015.
8. Institute of Medicine (IOM). Preventing medication errors: Quality Chasm Series. Washington, DC: National Academies Press, 2007.
9. American College of Clinical Pharmacy (ACCP). Standards of practice for clinical pharmacists. Pharmacotherapy 2014; 34: 794-7.
10. Bluml BM,. Definition of medication therapy management: development of professionwide consensus. J Am Pharm Assoc 2005; 45: 566-72.
11. McInnis T, Strand LM, Webb CE,. The patient-centered medical home: integrating comprehensive medication management to optimize patient outcomes, 2nd ed. Patient-Centered Primary Care Collaborative, 2012. Available from https://www.accp.com/docs/positions/misc/CMM%20Resource%20Guide.pdf. Accessed January 6, 2015.
12. Pew Health Professions Commission. Recreating health professional practice for a new century. San Francisco, CA: Pew Charitable Trust, 1998.
13. Kohn LT, Corrigan JM, Donaldson MS, eds. Institute of Medicine (IOM). To err is human: building a safer health system. Washington, DC: National Academy Press, 2000.
14. Institute of Medicine (IOM). Crossing the quality chasm: a new health system for the 21st century. Washington, DC: National Academies Press, 2001.
15. Gattis WA, Hasselblad V, Whellan DJ, O'Connor CM,. Reduction in heart failure events by the addition of a clinical pharmacist to the heart failure management team: results of the Pharmacist in Heart Failure Assessment Recommendation and Monitoring (PHARM) study. Arch Intern Med 1999; 159: 1939-45.
16. World Health Organization. World health statistics 2014. Available from http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671-eng.pdf. Accessed January 9, 2015.
17. Centers for Medicare and Medicaid Services. National Health Expenditure Data: NHE Fact Sheet. Available from http://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/NHE-Fact-Sheet.html. Accessed January 7, 2015.
18. Congressional Budget Office. Congress of the United States. Updated Estimates of the Effects of the Insurance Coverage Provisions of the Affordable Care Act, April 2014. Available from http://www.cbo.gov/sites/default/files/45231-ACA-Estimates.pdf. Accessed January 7, 2015.
19. U.S. Department of Health and Human Services (DHHS), National Center for Health Statistics. Health, United States, 2011: with special feature on socioeconomic status and health. Hyattsville, MD: DHHS, 2012.
20. Thomas K,. U.S. drug costs dropped in 2012, but rises loom. New York Times. Available from www.nytimes.com/2013/03/19/business/use-of-generics-produces-an-unusual-drop-in-drug-spending.html?pagewanted=all&-r=0. Accessed January 6, 2015.
21. Centers for Medicare and Medicaid Services. National Health Expenditure 2013 Highlights. Available from www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/downloads/highlights.pdf. Accessed January 9, 2015.
22. American Society of Health-System Pharmacists (ASHP). Pharmacy Practice Model Initiative. Available from www.ashpmedia.org/ppmi/. Accessed January 6, 2015.
23. Odum L, Whaley-Connell A,. The role of team-based care involving pharmacists to improve cardiovascular and renal outcomes. Cardiorenal Med 2012; 2: 243-50.
24. Mitchell P, Wynia M, Golden R, et al. Core principles & values of effective team-based health care. Washington, DC: IOM, 2012.
25. Blank C,. Minn. ACO uses MTM to reduce hospital readmissions. Drug Topics. Available from http://drugtopics.modernmedicine.com/drug-topics/news/modernmedicine/modern-medicine-news/minn-aco-uses-mtm-reduce-hospital-readmissions. Accessed January 6, 2015.
26. Fillmore H, Dubard CA, Ritter GA, Jackson CT,. Health care savings with the patient-centered medical home: Community Care of North Carolina's experience. Popul Health Manag 2014; 17: 141-8.
27. Edwards HD, Webb RD, Scheid DC, Britton ML, Armor BL,. A pharmacist visit improves diabetes standards in a patient-centered medical home (PCMH). Am J Med Qual 2012; 27: 529-34.
28. Berdine HJ, Skomo ML,. Development and integration of pharmacist clinical services into the patient-centered medical home. J Am Pharm Assoc 2012; 52: 661-7.
29. Anderson SL, Marrs JC, Vande Griend JP, Hanratty R,. Implementation of a clinical pharmacy specialist-managed telephonic hospital discharge follow-up program in a patient-centered medical home. Popul Health Manag 2013; 16: 235-41.
30. Bates DW,. Role of pharmacists in the medical home. Am J Health Syst Pharm 2009; 66: 1116-8.
31. Berdine H, Dougherty T, Ference J, et al. The pharmacists' role in the Patient-Centered Medical Home (PCMH): a white paper created by the Health Policy Committee of the Pennsylvania Pharmacists Association (PPA). Ann Pharmacother 2012; 46: 723-50.
32. Lipton HL,. Pharmacists and health reform: go for it! Pharmacotherapy 2010; 30: 967-72.
33. American College of Clinical Pharmacy (ACCP). Board of Regents commentary. Qualifications of pharmacists who provide direct patient care: perspectives on the need for residency training and board certification. Pharmacotherapy 2013; 33: 888-91.
34. Philip B, Weber RJ,. Enhancing pharmacy practice models through pharmacists' privileging. Hosp Pharm 2013; 48: 160-5.
35. Centers for Medicare & Medicaid Services (CMS), Department of Health and Human Services (DHHS). Medicare and Medicaid programs; reform of hospital and critical access hospital conditions of participation. Final rule. Fed Regist 2012; 77: 29034-76.
36. U.S. Department of Veterans Affairs. Scope of practice for pharmacists with direct patient care, 119: Pharmacy Service. Available from www.va.gov/vhapublications/publications.cfm?pub=1. Accessed January 6, 2015.
37. Centers for Medicare & Medicaid Services (CMS). Lower costs, better care: reforming our health care delivery system. Available from www.cms.gov/Newsroom/MediaReleaseDatabase/Fact-Sheets/2013-Fact-Sheets-Items/2013-02-28.html. Accessed January 6, 2015.
38. Centers for Medicare & Medicaid Services (CMS). Hospital Compare. Available from www.medicare.gov/hospitalcompare. Accessed January 6, 2015.
39. HCAHPSOnline.org [home page on the Internet]. Hospital Consumer Assessment of Healthcare Providers and Systems survey. Available from www.hcahpsonline.org. Accessed January 6, 2015.
40. CMS.gov [home page on the Internet]. Atlanta, GA: Centers for Medicare & Medicaid Services (CMS). Available from www.cms.gov. Accessed January 6, 2015.
41. National Committee for Quality Assurance (NCQA). HEDIS measures. Available from www.ncqa.org/HEDISQualityMeasurement/HEDISMeasures.aspx. Accessed January 6, 2015.
42. Buckley B,. Tales of success in boosting HCAHPS scores. Pharmacy Practice News 2012;39. Available from www.pharmacypracticenews.com/ViewArticle.aspx?d=Operations%2B%26%2BManagement&d-id=53&i=August+2012&i-id=872&a-id=21375 [requires Web site registration]. Accessed January 6, 2015.
43. Avery AJ, Rodgers S, Cantrill JA, et al. A pharmacist-led information technology intervention for medication errors (PINCER): a multicentre, cluster randomised, controlled trial and cost-effectiveness analysis. Lancet 2012; 379: 1310-9.
44. Bell CM, Brener SS, Gunraj N, et al. Association of ICU or hospital admission with unintentional discontinuation of medications for chronic diseases. JAMA 2011; 306: 840-7.
45. Budnitz DS, Lovegrove MC, Shehab N, Richards CL,. Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 2011; 365: 2002-12.
46. Guthrie B, McCowan C, Davey P, Simpson CR, Dreischulte T, Barnett K,. High risk prescribing in primary care patients particularly vulnerable to adverse drug events: cross sectional population database analysis in Scottish general practice. BMJ 2011; 342: d3514.
47. National Association of Boards of Pharmacy (NABP). Model State pharmacy act and model rules of the National Association of Boards of Pharmacy. Mount Prospect, IL: NABP, 2012.
48. Hernandez E,. California Senate Bill 493. An act to amend Sections 733, 4040, 4050, 4051, 4052, 4052.3, 4060, 4076, 4111, and 4174 of, and to add Sections 4016.5, 4052.6, 4052.8, 4052.9, 4210, and 4233 to, the Business and Professions Code, relating to pharmacy. Available from www.leginfo.ca.gov/pub/13-14/bill/sen/sb-0451-0500/sb-493-bill-20131001-chaptered.htm. Accessed January 6, 2015.
49. Touchette DR, Doloresco F, Suda KJ, et al. Economic evaluation of clinical pharmacy services: 2006-2010. Pharmacotherapy 2014; 34: 771-93.
50. Perez A, Doloresco F, Hoffman JM, et al. ACCP: economic evaluations of clinical pharmacy services: 2001-2005. Pharmacotherapy 2009; 29: 128.
51. Schumock GT, Meek PD, Ploetz PA, Vermeulen LC,. Economic evaluations of clinical pharmacy services-1988-1995. The Publications Committee of the American College of Clinical Pharmacy. Pharmacotherapy 1996; 16: 1188-208.
52. Schumock GT, Butler MG, Meek PD, Vermeulen LC, Arondekar BV, Bauman JL,. Evidence of the economic benefit of clinical pharmacy services: 1996-2000. Pharmacotherapy 2003; 23: 113-32.
53. U.S. Department of Health and Human Services. Special report to the Senate Appropriations Committee on advancing clinical pharmacy services in programs funded by the Health Resources and Services Administration and its Safety-Net Partners. Senate Report 110-107. 2008. Available from https://docs.340bpvp.com/documents/public/resourcecenter/HRSA-ACPS-report.pdf. Accessed January 6, 2015.
54. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA 1999; 282: 267-70.
55. Hamblin S, Rumbaugh K, Miller R,. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach. J Trauma Acute Care Surg 2012; 73: 1484-90.
56. Smith M, Bates DW, Bodenheimer T, Cleary PD,. Why pharmacists belong in the medical home. Health Aff 2010; 29: 906-13.
57. Reid RJ, Fishman PA, Yu O, et al. Patient-centered medical home demonstration: a prospective, quasi-experimental, before and after evaluation. Am J Manag Care 2009; 15: e71-87.
58. Heilmann RM, Campbell SM, Kroner BA, et al. Evolution, current structure, and role of a primary care clinical pharmacy service in an integrated managed care organization. Ann Pharmacother 2013; 47: 124-31.
59. DaVanzo J, Dobson A, Koenig L, Book R,. Medication therapy management services: a critical review. J Am Pharm Assoc 2005; 45: 580-7.
60. Steinbrook R,. The end of fee-for-service medicine? Proposals for payment reform in Massachusetts. N Engl J Med 2009; 361: 1036-8.
61. National Commission on Physician Payment Reform. Available from http://physicianpaymentcommission.org/. Accessed January 6, 2015.
62. Lenz TL, Monaghan MS,. Pay-for-performance model of medication therapy management in pharmacy practice. J Am Pharm Assoc 2011; 51: 425-31.
63. Lindenauer PK, Remus D, Roman S, et al. Public reporting and pay for performance in hospital quality improvement. N Engl J Med 2007; 356: 486-96.
64. Van Herck P, De Smedt D, Annemans L, Remmen R, Rosenthal MB, Sermeus W,. Systematic review: effects, design choices, and context of pay-for-performance in health care. BMC Health Serv Res 2010; 10: 247.
65. Cutler TW, Palmieri J, Khalsa M, Stebbins M,. Evaluation of the relationship between a chronic disease care management program and California pay-for-performance diabetes care cholesterol measures in one medical group. J Manag Care Pharm 2007; 13: 578-88.
66. Scott A, Sivey P, Ait Ouakrim D, et al. The effect of financial incentives on the quality of health care provided by primary care physicians. Cochrane Database Syst Rev 2011; 9: CD008451.
67. Bardach NS, Wang JJ, De Leon SF, et al. Effect of pay-for-performance incentives on quality of care in small practices with electronic health records: a randomized trial. JAMA 2013; 310: 1051-9.
68. Robinson JC,. Blended payment methods in physician organizations under managed care. JAMA 1999; 282: 1258-63.
69. Stump AL,. Creating a fee schedule for the pharmacist CPT codes based on revenue value units (online presentation). American Society of Health-System Pharmacists. Available from www.ashp.org/DocLibrary/MemberCenter/Webinars/Fee-Schedule-Revenue-Value-Units.aspx. Accessed January 6, 2015.